These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17135255)

  • 21. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor.
    Schaufele F; Chang CY; Liu W; Baxter JD; Nordeen SK; Wan Y; Day RN; McDonnell DP
    Mol Endocrinol; 2000 Dec; 14(12):2024-39. PubMed ID: 11117532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta.
    Routledge EJ; White R; Parker MG; Sumpter JP
    J Biol Chem; 2000 Nov; 275(46):35986-93. PubMed ID: 10964929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of a new yeast-based reporter assay consisting of human estrogen receptors alpha/beta and coactivator SRC-1: application for detection of estrogenic activity in environmental samples.
    Chu WL; Shiizaki K; Kawanishi M; Kondo M; Yagi T
    Environ Toxicol; 2009 Oct; 24(5):513-21. PubMed ID: 19161236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries.
    Northrop JP; Nguyen D; Piplani S; Olivan SE; Kwan ST; Go NF; Hart CP; Schatz PJ
    Mol Endocrinol; 2000 May; 14(5):605-22. PubMed ID: 10809226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains.
    Kobayashi Y; Kitamoto T; Masuhiro Y; Watanabe M; Kase T; Metzger D; Yanagisawa J; Kato S
    J Biol Chem; 2000 May; 275(21):15645-51. PubMed ID: 10747867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
    Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
    J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators.
    Lopez GN; Webb P; Shinsako JH; Baxter JD; Greene GL; Kushner PJ
    Mol Endocrinol; 1999 Jun; 13(6):897-909. PubMed ID: 10379889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligands differentially modulate the protein interactions of the human estrogen receptors alpha and beta.
    Margeat E; Bourdoncle A; Margueron R; Poujol N; Cavaillès V; Royer C
    J Mol Biol; 2003 Feb; 326(1):77-92. PubMed ID: 12547192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-function evaluation of ER alpha and beta interplay with SRC family coactivators. ER selective ligands.
    Wong CW; Komm B; Cheskis BJ
    Biochemistry; 2001 Jun; 40(23):6756-65. PubMed ID: 11389589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant.
    Sauvé F; McBroom LD; Gallant J; Moraitis AN; Labrie F; Giguère V
    Mol Cell Biol; 2001 Jan; 21(1):343-53. PubMed ID: 11113208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
    Kraichely DM; Sun J; Katzenellenbogen JA; Katzenellenbogen BS
    Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha.
    Wärnmark A; Treuter E; Gustafsson JA; Hubbard RE; Brzozowski AM; Pike AC
    J Biol Chem; 2002 Jun; 277(24):21862-8. PubMed ID: 11937504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear hormone receptor coregulator GRIP1 suppresses, whereas SRC1A and p/CIP coactivate, by domain-specific binding of MyoD.
    Wu HY; Hamamori Y; Xu J; Chang SC; Saluna T; Chang MF; O'Malley BW; Kedes L
    J Biol Chem; 2005 Feb; 280(5):3129-37. PubMed ID: 15563453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1.
    Stenoien DL; Mancini MG; Patel K; Allegretto EA; Smith CL; Mancini MA
    Mol Endocrinol; 2000 Apr; 14(4):518-34. PubMed ID: 10770489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen receptor beta isoform-specific induction of transforming growth factor beta-inducible early gene-1 in human osteoblast cells: an essential role for the activation function 1 domain.
    Hawse JR; Subramaniam M; Monroe DG; Hemmingsen AH; Ingle JN; Khosla S; Oursler MJ; Spelsberg TC
    Mol Endocrinol; 2008 Jul; 22(7):1579-95. PubMed ID: 18483178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen receptor-related receptor alpha 1 interacts with coactivator and constitutively activates the estrogen response elements of the human lactoferrin gene.
    Zhang Z; Teng CT
    J Biol Chem; 2000 Jul; 275(27):20837-46. PubMed ID: 10779508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of tetrahydrocrysene ketone with estrogen receptors alpha and beta indicates conformational differences in the receptor subtypes.
    Tyulmenkov VV; Klinge CM
    Arch Biochem Biophys; 2000 Sep; 381(1):135-42. PubMed ID: 11019829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres.
    Iannone MA; Consler TG; Pearce KH; Stimmel JB; Parks DJ; Gray JG
    Cytometry; 2001 Aug; 44(4):326-37. PubMed ID: 11500849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ligand and DNA binding on the interaction between human transcription intermediary factor 1alpha and estrogen receptors.
    Thénot S; Bonnet S; Boulahtouf A; Margeat E; Royer CA; Borgna JL; Cavaillès V
    Mol Endocrinol; 1999 Dec; 13(12):2137-50. PubMed ID: 10598587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner.
    Ramsey TL; Risinger KE; Jernigan SC; Mattingly KA; Klinge CM
    Endocrinology; 2004 Jan; 145(1):149-60. PubMed ID: 14500565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.